Long-term Debt - Additional Information (Details) - USD ($)		3 Months Ended		6 Months Ended
	Oct. 18, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Line of Credit Facility [Line Items]
Common stock par value		$ 0.0001		$ 0.0001		$ 0.0001
Net product sale equals or exceeds amount		$ 15,195,000	$ 11,753,000	$ 26,299,000	$ 22,303,000
Debt instrument unpaid principal balance		40,000,000		40,000,000
Debt instrument outstanding amount addition (reduction) to liability		$ 989,000		$ 989,000		$ (188,000)
Senior Secured Credit Facility | OrbiMed
Line of Credit Facility [Line Items]
Common stock par value	$ 0.0001
Credit agreement term	5 years
Line of credit facility description				On October 18, 2023 (the “Closing Date”) the Company entered into a credit agreement, by and between the Company, as borrower, and an affiliate of OrbiMed Advisors, LLC (the “Lender”) as the lender and administrative agent (the "Credit Agreement") . The Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $90.0 million, of which (i) $40.0 million was made available on the Closing Date (the “Initial Commitment Amount”), (ii) $25.0 million is available, at the Company’s discretion, on or prior to December 31, 2024, subject to certain net revenue requirements, and (iii) $25.0 million is available, at the Company’s discretion, on or prior to June 30, 2025, subject to certain net revenue requirements. The maturity date of the agreement is October 18, 2028 (the "Maturity Date"). On the Closing Date, the Company closed on the Initial Commitment Amount of $40.0 million, less certain fees and expenses payable to or on behalf of the Lender. The Company received net proceeds of $38.8 million upon closing after deducting the Lender's transaction costs in connection with the issuance.
Aggregate principal amount	$ 90,000,000
Current borrowing capacity	$ 40,000,000
Maturity date	Oct. 18, 2028
Proceeds from debt, net of issuance costs	$ 38,800,000
Line of credit facility, exit fee percentage	3.00%
Quarterly installment percentage of outstanding principal amount	5.00%
Repayments on outstanding debt				$ 0
Debt Instrument, fixed percentage	4.00%	13.33%		13.33%
Debt Instrument, variable percentage	8.00%
Undrawn fee accrues percentage of undrawn balance amount	0.50%
Warrants, exercise price	$ 10.9847
Warrants, expiration term	10 years
Senior Secured Credit Facility | OrbiMed | Maximum
Line of Credit Facility [Line Items]
Line of credit facility, repayment premium percentage	3.00%
Number of shares purchased, warrants	409,661
Senior Secured Credit Facility | OrbiMed | Minimum
Line of Credit Facility [Line Items]
Line of credit facility, repayment premium percentage	0.00%
Unrestricted cash and cash equivalents	$ 10,000,000
Senior Secured Credit Facility | OrbiMed | First Tranche On or Prior to December 31, 2024
Line of Credit Facility [Line Items]
Remaining borrowing capacity	25,000,000
Senior Secured Credit Facility | OrbiMed | Second Tranche On or Prior to June 30, 2025
Line of Credit Facility [Line Items]
Remaining borrowing capacity	$ 25,000,000